Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.
published in: Journal of Inherited Metabolic Disease
date of publication: 2004-01-01
Cites articles 13
Date
Title
Article - wd:Q42638927